Home › Companies › NH Nongwoobio

NH Nongwoobio

NH농우바이오 · 054050 · KOSDAQ
Filings, last 12 months
42
Supply contracts
0
Insider reports
1
Share & bond issues
0

At a glance

NH Nongwoobio filed 42 disclosures in the last 12 months, including 1 earnings, 1 insider and 1 m&a. The most recent key filing was on Sep 29.

Revenue for 2025 was ₩159B, up 9.8% on 2024. Operating margin was 8.6% against 7.7% a year earlier. Debt was 27% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩82.5B and operating profit of ₩7.9B.

The 2025 annual report lists 378 employees with an average tenure of 12.6 years and average pay of ₩77.2M, #438 of 1,829 listed companies by average pay. Its 11 directors and auditors were paid ₩54M each on average. It paid ₩250 per common share in cash dividends, against ₩220 a year earlier (+13.6%). 농협경제지주(주) and related parties held 57.99% at year end.

From the 2025 annual report

Employees
378
Average pay
₩77.2M
Average tenure
12.6 yrs
Avg. director pay
₩54M

Staff: 378 (254 men, 124 women), of whom 41 on fixed-term contracts. Total pay for the year: ₩29.2B. Directors and auditors: 11, paid ₩590M in total.

Dividends (common shares)

Fiscal year202520242023
Cash dividend per share₩250₩220₩200
Payout ratio32.6%32.3%31.1%
Yield (as filed)3.00%3.00%2.40%
Total cash dividends₩4B₩3.5B₩3.2B

Largest shareholder

농협경제지주(주) holds 57.91%; with 2 related parties the group holds 57.99% of common shares at year end (from 57.94% at the start of the year).

Auditor: 안진회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

2023
Revenue ₩136B
Op. profit ₩8.9B
Debt/equity 26%
2024
Revenue ₩145B
Op. profit ₩11.1B
Debt/equity 26%
2025
Revenue ₩159B
Op. profit ₩13.6B
Debt/equity 27%
2026 H1
Revenue ₩82.5B
Op. profit ₩7.9B
Debt/equity 26%
RevenueOperating profitOperating lossConsolidated where available · from periodic reports

Key filings

Other filings

Links open the original filing on DART, in Korean.